Home Teva Agrees to Buy NuPathe for $144 Million, Outbidding Endo
 

Keywords :   


Teva Agrees to Buy NuPathe for $144 Million, Outbidding Endo

2014-01-21 19:16:48| Biotech - Topix.net

Teva Pharmaceutical Industries Ltd. agreed to buy NuPathe Inc. for $144 million, outbidding Endo Health Solutions Inc. to gain NuPathe's migraine patch.

Tags: buy million agrees endo

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
18.06Farm Progress America, June 18, 2024
18.06Farm Progress America, June 18, 2024
18.06Potential Tropical Cyclone One Graphics
18.06Potential Tropical Cyclone One Forecast Discussion Number 3
18.06Potential Tropical Cyclone One Wind Speed Probabilities Number 3
18.06Potential Tropical Cyclone One Public Advisory Number 3
18.06Summary for Potential Tropical Cyclone One (AT1/AL012024)
18.06Potential Tropical Cyclone One Forecast Advisory Number 3
More »